IP Library Granted Patent US 7,871,659
Granted Patent B2
US 7,871,659 · App. 12/106,064 · Granted Jan 18, 2011

Method of visualizing medical devices during implantation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,871,659
App. No.
12/106,064
Granted
Jan 18, 2011
Kind
B2
Abstract

A method of rapid visualization of an implantable medical device using technology for viewing inside of a mammalian body. These technologies include ultrasound echocardiography and video imaging such as that used during laparoscopic procedures.

Claims (13)

1. A method of visualizing a medical device during implantation thereof with ultrasonic imaging, said method comprising:

(a) providing a medical device having at least a portion thereof made of an opaque porous expanded polytetrafluoroethylene material and at least one dried, covalently cross-linked, hydrophilic polymeric material placed in pores of said porous expanded polytetrafluoroethylene material;

(b) exposing said medical device to an aqueous medium in vivo;

(c) permitting said aqueous medium to contact said hydrophilic polymeric material in pores of said porous expanded polytetrafluoroethylene material;

(d) visualizing said medical device with ultrasonic imaging in the presence of said aqueous medium; and

(e) observing at least a portion of said opaque porous expanded polvtetrafluoroethylene material becoming translucent or transparent during said ultrasonic imaging.

2. The method of claim 1 wherein said aqueous medium is blood.

3. The method of claim 1 , wherein the visualizing takes about thirty seconds or less.

4. The method of claim 1 , wherein the visualizing takes about ten to five seconds or less.

5. The method of claim 1 , wherein the visualizing is substantially instantaneous.

6. The method of claim 1 , wherein the hydrophilic polymeric material is selected from the group consisting of polyvinyl alcohol, polyethylene glycol, polypropylene glycol, dextran, agarose, alginate, polyacrylamide, polyglycidol, poly(vinyl alcohol-co-ethylene), poly(ethyleneglycol-co-propyleneglycol), poly(vinyl acetate-co-vinyl alcohol), poly(tetrafluoroethylene co-vinyl alcohol), poly(acrylonitrile-co-acrylamide), poly(acrylonitrile-co-acryl-ic acid-co-acrylamide), polyacrylic acid, poly-lysine, polyethyleneimine, polyvinyl pyrrolidone, polyhydroxyethylmethacrylate, polysulfone, and combinations thereof.

7. The method of claim 1 , wherein the hydrophilic polymeric material is cross-linked with a cross-linking agent comprising compounds having at least two chemically functional groups selected from the group consisting of homofunctional, heterofunctional, and combinations thereof.

8. The method of claim 1 , wherein the hydrophilic polymeric material is cross-linked with a cross-linking agent selected from the group consisting of aldehydes, epoxides, acyl halides, aryl halides, isocyanates, amines, anhydrides, acids, alcohols, haloacetals, arylcarbonates, thiols, esters, imides, vinyls, azides, nitros, peroxides, sulfones, maleimides and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2012
From: GORE ENTERPRISE HOLDINGS, INC.
To: W. L. GORE & ASSOCIATES, INC.
Reel/Frame 027906/0508 →